BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34606083)

  • 1. Robotic versus Laparoscopic Retroperitoneal Lymph node Dissection for Clinical Stage I Non-seminomatous Germ Cell Tumor of Testis: A Comparative Analysis.
    Xu Y; Li H; Wang B; Gu L; Gao Y; Fan Y; Yao Y; Fam X; Ma X; Zhang X
    Urol J; 2021 Oct; 18(6):618-622. PubMed ID: 34606083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Early Oncologic Effectiveness of Primary Robotic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer.
    Pearce SM; Golan S; Gorin MA; Luckenbaugh AN; Williams SB; Ward JF; Montgomery JS; Hafez KS; Weizer AZ; Pierorazio PM; Allaf ME; Eggener SE
    Eur Urol; 2017 Mar; 71(3):476-482. PubMed ID: 27234998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of laparoscopic, robotic, and open retroperitoneal lymph node dissection for non-seminomatous germ cell tumor: a single-center retrospective cohort study.
    Lin J; Hu Z; Huang S; Shen B; Wang S; Yu J; Wang P; Jin X
    World J Urol; 2023 Jul; 41(7):1877-1883. PubMed ID: 37332060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of robotic vs laparoscopic retroperitoneal lymph node dissection for testicular cancer.
    Harris KT; Gorin MA; Ball MW; Pierorazio PM; Allaf ME
    BJU Int; 2015 Dec; 116(6):920-3. PubMed ID: 25781349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular Tumors.
    Pickersgill NA; Raval NS; Kim EH; Black RG; Du K; Figenshau RS
    Clin Genitourin Cancer; 2021 Jun; 19(3):273.e1-273.e5. PubMed ID: 33139148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.
    Supron AD; Cheaib JG; Biles MJ; Schwen Z; Allaf M; Pierorazio PM
    J Robot Surg; 2021 Apr; 15(2):309-313. PubMed ID: 32572754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic and open retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumors.
    Abdel-Aziz KF; Anderson JK; Svatek R; Margulis V; Sagalowsky AI; Cadeddu JA
    J Endourol; 2006 Sep; 20(9):627-31. PubMed ID: 16999613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans- and extraperitoneal retroperitoneal lymph node dissection (RPLND) in the treatment for nonseminomatous germ cell testicular tumors (NSGCT): a single Chinese center's retrospective analysis.
    Tong S; Chen M; Zu X; Li Y; He W; Lei Y; Liu W; Qi L
    Int Urol Nephrol; 2014 Feb; 46(2):363-9. PubMed ID: 23996573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.
    Lloyd P; Hong A; Furrer MA; Lee EWY; Dev HS; Coret MH; Adshead JM; Baldwin P; Knight R; Shamash J; Alifrangis C; Stoneham S; Mazhar D; Wong H; Warren A; Tran B; Lawrentschuk N; Neal DE; Thomas BC
    World J Urol; 2022 Jan; 40(1):119-126. PubMed ID: 34599350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients.
    Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S
    J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours.
    Ohlmann CH; Saar M; Pierchalla LC; Zangana M; Bonaventura A; Stöckle M; Siemer S; Heinzelbecker J
    Sci Rep; 2021 May; 11(1):10700. PubMed ID: 34021196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes.
    Rocco NR; Stroup SP; Abdul-Muhsin HM; Marshall MT; Santomauro MG; Christman MS; L'Esperance JO; Castle EP
    World J Urol; 2020 Apr; 38(4):859-867. PubMed ID: 31502033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].
    Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511
    [No Abstract]   [Full Text] [Related]  

  • 18. Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage I nonseminomatous germ cell tumors.
    Guzzo TJ; Gonzalgo ML; Allaf ME
    J Endourol; 2010 Nov; 24(11):1759-63. PubMed ID: 20879859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Effectiveness of Risk-adapted Surveillance vs Retroperitoneal Lymph Node Dissection in Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer: A Retrospective Follow-up Study of 81 Patients.
    Fan G; Zhang L; Yi L; Jiang ZQ; Ke Y; Wang XS; Xiong YY; Han WQ; Zhou X; Liu C; Yu X
    Asian Pac J Cancer Prev; 2015; 16(8):3267-72. PubMed ID: 25921130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors.
    Bhanvadia R; Ashbrook C; Bagrodia A; Lotan Y; Margulis V; Woldu S
    World J Urol; 2021 Jun; 39(6):1977-1984. PubMed ID: 32797261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.